Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Antidiabetic effects of GW-0072, a new SPARM, examined in animal model of type 2 diabetes

Sep. 10, 2001

Org-30659 comparable to desogestrel for effects on ovarian function

Sep. 7, 2001

Synthetic SOD/catalase mimetic may prove useful in sideroblastic anemia

Sep. 7, 2001

Cialis NDA accepted for FDA review

Sep. 7, 2001

Piperidine urea-based compounds selective for human beta3-adrenoceptors

Sep. 7, 2001

GSK identifies candidate Y5 antagonist for efficacy studies in obesity

Sep. 6, 2001

New compounds with estrogenic or antiestrogenic effects claimed by Pfizer

Sep. 4, 2001

BMS files IND for obesity drug candidate developed with Karo Bio

Sep. 4, 2001

Hybrid molecule enhances insulin secretion and reduces insulin resistance

Sep. 4, 2001

Safe and effective glucose-lowering agents prepared at Kyowa Hakko

Sep. 3, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
Insilico Medicine synthesizes new Nav1.8 blockers
BioWorld Science
Insilico Medicine Inc. has identified sodium channel protein type 10 subunit α (SCN10A; Nav1.8) blockers that are potentially useful for the treatment of pain.